Marijuana Study Finds CBD Can Cause Liver Damage

Stuart SchlossmanCANNABIS, Complementary & Alternative therapies and devices for Multiple Sclerosis (MS)

written by: Mike Adams -Contributor

There is no denying that cannabidiol, more commonly referred to as CBD, is rapidly becoming more popular in the United States than sliced bread. It is a hot trend that got started several years ago after Dr. Sanja Gupta showed the nation in his documentary ‘Weed 2’ just how this non-intoxicating component of the cannabis plant was preventing epileptic children from having seizures. 

Hemp oil, Hand holding bottle of Cannabis oil against Marijuana plant, CBD oil pipette.   alternative remedy or medication,medicine concept

Hemp oil, Hand holding bottle of Cannabis oil against Marijuana plant, CBD oil pipette. alternative remedy or medication,medicine concept – 

GETTY

Since then, CBD, a substance often touted as being safer than popping pills, has become highly revered as an alternative treatment for a variety of common ailments from anxiety to chronic pain. But a new study suggests that CBD may spawn its fair share of health issues. Specifically, scientists have learned that this substance could be damaging our livers in the same way as alcohol and other drugs. 
Researchers at the University of Arkansas for Medical Science recently rolled up their sleeves to investigate CBD hepatotoxicity in mice. What they found was while this cannabis derivative is gaining significant recognition as of late in the world of wellness, people that use CBD are at an elevated risk for liver toxicity.
The findings, which were published earlier this year in the journal Molecules, suggest that while people may be using CBD as a safer alternative to conventional pain relievers, like acetaminophen, the compound may actually be just as harmful to their livers. 
It is the methods used in this study that makes it most interesting.

First, researchers utilized all of the dosage and safety recommendations from a CBD-based drug known as Epidiolex. If this name sounds familiar, it should. Last year, the U.S. Food and Drug Administration approved it as a treatment for certain kinds of childhood epilepsy. It was a development that marked the first time in history that a cannabis-based medicine was approved for nationwide distribution in the United States. 

Read More

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive The MS BEACON’ e-Newsletter, Click here

——————————————————————–

CLICK Red BOX to SUBSCRIBE to our MS Learning Channel 

Click Red Box on banner to opt-in
——————————————————————–
——————————————————————–
This Article is Provided by:  #MSViewsandNews
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews